0 XP   0   0   0

Sequana Medical NV
Buy, Hold or Sell?

Should you buy, hold or sell Sequana Medical NV?

I guess you are interested in Sequana Medical NV. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Sequana Medical NV

Let's start. I'm going to help you getting a better view of Sequana Medical NV. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Sequana Medical NV even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Sequana Medical NV is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Sequana Medical NV. The closing price on 2023-01-30 was €5.48 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Sequana Medical NV Daily Candlestick Chart
Sequana Medical NV Daily Candlestick Chart
Summary









1. Valuation of Sequana Medical NV




Current price per share

€5.48

2. Growth of Sequana Medical NV




Is Sequana Medical NV growing?

Current yearPrevious yearGrowGrow %
How rich?-$853.9k$122.3k-$976.3k-114.3%

How much money is Sequana Medical NV making?

Current yearPrevious yearGrowGrow %
Making money-$25.6m-$20.7m-$4.8m-19.1%
Net Profit Margin-6,373.8%-1,983.5%--

How much money comes from the company's main activities?

3. Financial Health of Sequana Medical NV




Comparing to competitors in the Medical Devices industry




  Industry Rankings (Medical Devices)  


Richest
#361 / 390

Most Revenue
#318 / 390

Most Profit
#348 / 390

Most Efficient
#373 / 390


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.

1.1. Profitability of Sequana Medical NV.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Sequana Medical NV earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Sequana Medical NV to the Medical Devices industry mean.
  • A Net Profit Margin of -6,373.8% means that €-63.74 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Sequana Medical NV:

  • The MRQ is -6,373.8%. The company is making a huge loss. -2
  • The TTM is -6,373.8%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-6,373.8%TTM-6,373.8%0.0%
TTM-6,373.8%YOY-1,983.5%-4,390.4%
TTM-6,373.8%5Y-2,378.0%-3,995.9%
5Y-2,378.0%10Y-1,930.6%-447.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-6,373.8%-16.2%-6,357.6%
TTM-6,373.8%-15.7%-6,358.1%
YOY-1,983.5%-15.1%-1,968.4%
5Y-2,378.0%-22.6%-2,355.4%
10Y-1,930.6%-24.7%-1,905.9%
1.1.2. Return on Assets

Shows how efficient Sequana Medical NV is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Sequana Medical NV to the Medical Devices industry mean.
  • -160.6% Return on Assets means that Sequana Medical NV generated €-1.61 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Sequana Medical NV:

  • The MRQ is -160.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -160.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-160.6%TTM-160.6%0.0%
TTM-160.6%YOY-134.4%-26.2%
TTM-160.6%5Y-221.5%+60.9%
5Y-221.5%10Y-245.9%+24.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-160.6%-2.9%-157.7%
TTM-160.6%-2.8%-157.8%
YOY-134.4%-2.2%-132.2%
5Y-221.5%-3.6%-217.9%
10Y-245.9%-3.5%-242.4%
1.1.3. Return on Equity

Shows how efficient Sequana Medical NV is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Sequana Medical NV to the Medical Devices industry mean.
  • 0.0% Return on Equity means Sequana Medical NV generated €0.00 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Sequana Medical NV:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-16,943.8%+16,943.8%
TTM-5Y-3,712.3%+3,712.3%
5Y-3,712.3%10Y-2,651.6%-1,060.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--3.2%+3.2%
TTM--3.6%+3.6%
YOY-16,943.8%-1.9%-16,941.9%
5Y-3,712.3%-4.0%-3,708.3%
10Y-2,651.6%-4.3%-2,647.3%

1.2. Operating Efficiency of Sequana Medical NV.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Sequana Medical NV is operating .

  • Measures how much profit Sequana Medical NV makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Sequana Medical NV to the Medical Devices industry mean.
  • An Operating Margin of -6,113.2% means the company generated €-61.13  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Sequana Medical NV:

  • The MRQ is -6,113.2%. The company is operating very inefficient. -2
  • The TTM is -6,113.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-6,113.2%TTM-6,113.2%0.0%
TTM-6,113.2%YOY-1,855.5%-4,257.7%
TTM-6,113.2%5Y-2,253.2%-3,860.0%
5Y-2,253.2%10Y-1,838.1%-415.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-6,113.2%-15.2%-6,098.0%
TTM-6,113.2%-14.2%-6,099.0%
YOY-1,855.5%-11.0%-1,844.5%
5Y-2,253.2%-20.2%-2,233.0%
10Y-1,838.1%-22.3%-1,815.8%
1.2.2. Operating Ratio

Measures how efficient Sequana Medical NV is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 62.04 means that the operating costs are €62.04 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Sequana Medical NV:

  • The MRQ is 62.035. The company is inefficient in keeping operating costs low. -1
  • The TTM is 62.035. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ62.035TTM62.0350.000
TTM62.035YOY19.449+42.587
TTM62.0355Y23.453+38.582
5Y23.45310Y19.339+4.114
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ62.0351.418+60.617
TTM62.0351.283+60.752
YOY19.4491.231+18.218
5Y23.4531.325+22.128
10Y19.3391.289+18.050

1.3. Liquidity of Sequana Medical NV.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Sequana Medical NV is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 1.80 means the company has €1.80 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Sequana Medical NV:

  • The MRQ is 1.795. The company is able to pay all its short-term debts. +1
  • The TTM is 1.795. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.795TTM1.7950.000
TTM1.795YOY2.253-0.458
TTM1.7955Y1.281+0.514
5Y1.28110Y1.169+0.112
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7953.491-1.696
TTM1.7953.832-2.037
YOY2.2533.480-1.227
5Y1.2813.545-2.264
10Y1.1693.273-2.104
1.3.2. Quick Ratio

Measures if Sequana Medical NV is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Sequana Medical NV to the Medical Devices industry mean.
  • A Quick Ratio of 1.50 means the company can pay off €1.50 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Sequana Medical NV:

  • The MRQ is 1.497. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.497. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.497TTM1.4970.000
TTM1.497YOY1.903-0.406
TTM1.4975Y1.004+0.493
5Y1.00410Y0.816+0.188
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4971.723-0.226
TTM1.4972.035-0.538
YOY1.9031.879+0.024
5Y1.0041.805-0.801
10Y0.8161.775-0.959

1.4. Solvency of Sequana Medical NV.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Sequana Medical NV assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Sequana Medical NV to Medical Devices industry mean.
  • A Debt to Asset Ratio of 1.05 means that Sequana Medical NV assets are financed with 105.4% credit (debt) and the remaining percentage (100% - 105.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Sequana Medical NV:

  • The MRQ is 1.054. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 1.054. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ1.054TTM1.0540.000
TTM1.054YOY0.992+0.061
TTM1.0545Y2.374-1.321
5Y2.37410Y2.240+0.134
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0540.339+0.715
TTM1.0540.350+0.704
YOY0.9920.438+0.554
5Y2.3740.467+1.907
10Y2.2400.472+1.768
1.4.2. Debt to Equity Ratio

Measures if Sequana Medical NV is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Sequana Medical NV to the Medical Devices industry mean.
  • A Debt to Equity ratio of 0.0% means that company has €0.00 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Sequana Medical NV:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY125.048-125.048
TTM-5Y26.829-26.829
5Y26.82910Y19.164+7.666
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.462-0.462
TTM-0.462-0.462
YOY125.0480.581+124.467
5Y26.8290.632+26.197
10Y19.1640.688+18.476

2. Market Valuation of Sequana Medical NV

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Sequana Medical NV generates.

  • Above 15 is considered overpriced but always compare Sequana Medical NV to the Medical Devices industry mean.
  • A PE ratio of -10.06 means the investor is paying €-10.06 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Sequana Medical NV:

  • The EOD is -7.293. Company is losing money. -2
  • The MRQ is -10.061. Company is losing money. -2
  • The TTM is -10.061. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-7.293MRQ-10.061+2.768
MRQ-10.061TTM-10.0610.000
TTM-10.061YOY-14.666+4.605
TTM-10.0615Y-6.930-3.131
5Y-6.93010Y-4.950-1.980
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-7.293-6.306-0.987
MRQ-10.061-6.896-3.165
TTM-10.061-11.813+1.752
YOY-14.666-10.927-3.739
5Y-6.930-9.713+2.783
10Y-4.950-7.673+2.723
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Sequana Medical NV.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Sequana Medical NV:

  • The MRQ is -9.437. Very Bad. -2
  • The TTM is -9.437. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-9.437TTM-9.4370.000
TTM-9.437YOY-20.247+10.810
TTM-9.4375Y-13.456+4.019
5Y-13.45610Y-13.4560.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.4370.013-9.450
TTM-9.4370.046-9.483
YOY-20.2470.027-20.274
5Y-13.4560.068-13.524
10Y-13.4560.047-13.503

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Sequana Medical NV is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of -301.93 means the investor is paying €-301.93 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Sequana Medical NV:

  • The EOD is -218.856. Bad. Book ratio is negative. -2
  • The MRQ is -301.925. Bad. Book ratio is negative. -2
  • The TTM is -301.925. Bad. Book ratio is negative. -2
Trends
Current periodCompared to+/- 
EOD-218.856MRQ-301.925+83.069
MRQ-301.925TTM-301.9250.000
TTM-301.925YOY2,484.935-2,786.860
TTM-301.9255Y468.711-770.636
5Y468.71110Y334.793+133.917
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-218.8562.196-221.052
MRQ-301.9252.474-304.399
TTM-301.9253.559-305.484
YOY2,484.9354.220+2,480.715
5Y468.7113.471+465.240
10Y334.7933.042+331.751
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Sequana Medical NV compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.030-0.0300%-0.034+15%0.051-158%-0.004-88%
Book Value Growth---6.979-6.9790%0.122-5830%-1.114-84%-4.498-36%
Book Value Per Share---0.025-0.0250%0.005-627%-0.193+671%-0.180+618%
Book Value Per Share Growth---5.273-5.2730%0.122-4430%-0.772-85%-4.214-20%
Current Ratio--1.7951.7950%2.253-20%1.281+40%1.169+54%
Debt To Asset Ratio--1.0541.0540%0.992+6%2.374-56%2.240-53%
Debt To Equity Ratio----0%125.048-100%26.829-100%19.164-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.751-0.7510%-0.805+7%-0.624-17%-0.600-20%
Eps Growth--1.0661.0660%0.724+47%0.906+18%0.906+18%
Free Cash Flow Per Share---0.762-0.7620%-0.722-5%-0.609-20%-0.581-24%
Free Cash Flow Per Share Growth--0.9450.9450%1.089-13%0.861+10%0.861+10%
Free Cash Flow To Equity Per Share---0.048-0.0480%0.231-121%0.079-160%0.033-243%
Free Cash Flow To Equity Per Share Growth---0.208-0.2080%1.246-117%3.217-106%2.976-107%
Gross Profit Margin--1.0881.0880%1.122-3%1.151-6%1.179-8%
Intrinsic Value_10Y_max--0.944--------
Intrinsic Value_10Y_min--0.528--------
Intrinsic Value_1Y_max---0.579--------
Intrinsic Value_1Y_min---0.562--------
Intrinsic Value_3Y_max---1.225--------
Intrinsic Value_3Y_min---1.166--------
Intrinsic Value_5Y_max---1.253--------
Intrinsic Value_5Y_min---1.193--------
Net Profit Margin---63.738-63.7380%-19.835-69%-23.780-63%-19.306-70%
Operating Margin---61.132-61.1320%-18.555-70%-22.532-63%-18.381-70%
Operating Ratio--62.03562.0350%19.449+219%23.453+165%19.339+221%
Pb Ratio-218.856+28%-301.925-301.9250%2484.935-112%468.711-164%334.793-190%
Pe Ratio-7.293+28%-10.061-10.0610%-14.666+46%-6.930-31%-4.950-51%
Peg Ratio---9.437-9.4370%-20.247+115%-13.456+43%-13.456+43%
Price Per Share5.480-38%7.5607.5600%11.800-36%5.124+48%3.660+107%
Price To Total Gains Ratio-183.967+28%-253.794-253.7940%-344.588+36%-196.944-22%-196.944-22%
Profit Growth--0.7640.7640%0.724+5%0.826-7%0.820-7%
Quick Ratio--1.4971.4970%1.903-21%1.004+49%0.816+84%
Return On Assets---1.606-1.6060%-1.344-16%-2.215+38%-2.459+53%
Return On Equity----0%-169.4380%-37.1230%-26.5160%
Revenue Growth--0.3850.3850%0.992-61%0.797-52%0.811-53%
Total Gains Per Share---0.030-0.0300%-0.034+15%0.051-158%-0.004-88%
Total Gains Per Share Growth--1.1301.1300%-0.041+104%-0.015+101%-3.417+402%
Usd Book Value---853965.584-853965.5840%122370.408-798%-5017670.149+488%-4661841.291+446%
Usd Book Value Change Per Share---0.032-0.0320%-0.037+15%0.056-158%-0.004-88%
Usd Book Value Per Share---0.027-0.0270%0.005-627%-0.210+671%-0.195+618%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.815-0.8150%-0.873+7%-0.678-17%-0.651-20%
Usd Free Cash Flow---25983104.210-25983104.2100%-18603849.474-28%-16972567.844-35%-15892132.208-39%
Usd Free Cash Flow Per Share---0.827-0.8270%-0.783-5%-0.661-20%-0.631-24%
Usd Free Cash Flow To Equity Per Share---0.052-0.0520%0.251-121%0.086-160%0.036-243%
Usd Price Per Share5.947-38%8.2048.2040%12.805-36%5.561+48%3.972+107%
Usd Profit---25627085.901-25627085.9010%-20734053.666-19%-17343046.438-32%-16345996.370-36%
Usd Revenue--402066.600402066.6000%1045351.456-62%1006536.489-60%1210971.508-67%
Usd Total Gains Per Share---0.032-0.0320%-0.037+15%0.056-158%-0.004-88%
 EOD+2 -3MRQTTM+0 -0YOY+13 -265Y+14 -2510Y+14 -25

3.2. Fundamental Score

Let's check the fundamental score of Sequana Medical NV based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-7.293
Price to Book Ratio (EOD)Between0-1-218.856
Net Profit Margin (MRQ)Greater than0-63.738
Operating Margin (MRQ)Greater than0-61.132
Quick Ratio (MRQ)Greater than11.497
Current Ratio (MRQ)Greater than11.795
Debt to Asset Ratio (MRQ)Less than11.054
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-1.606
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Sequana Medical NV based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5028.821
Ma 20Greater thanMa 505.736
Ma 50Greater thanMa 1006.072
Ma 100Greater thanMa 2006.230
OpenGreater thanClose5.520
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2021-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets14,705
Total Liabilities15,492
Total Stockholder Equity-787
 As reported
Total Liabilities 15,492
Total Stockholder Equity+ -787
Total Assets = 14,705

Assets

Total Assets14,705
Total Current Assets12,891
Long-term Assets12,891
Total Current Assets
Cash And Cash Equivalents 9,600
Net Receivables 1,151
Inventory 2,139
Total Current Assets  (as reported)12,891
Total Current Assets  (calculated)12,891
+/- 0
Long-term Assets
Property Plant Equipment 1,268
Long-term Assets Other 546
Long-term Assets  (as reported)1,815
Long-term Assets  (calculated)1,815
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities7,180
Long-term Liabilities8,312
Total Stockholder Equity-787
Total Current Liabilities
Short-term Debt 283
Accounts payable 2,193
Other Current Liabilities 4,704
Total Current Liabilities  (as reported)7,180
Total Current Liabilities  (calculated)7,180
+/-0
Long-term Liabilities
Long term Debt 7,325
Capital Lease Obligations Min Short Term Debt477
Other Liabilities 510
Long-term Liabilities Other 0
Long-term Liabilities  (as reported)8,312
Long-term Liabilities  (calculated)8,312
+/- 0
Total Stockholder Equity
Common Stock1,925
Retained Earnings -142,695
Other Stockholders Equity 139,983
Total Stockholder Equity (as reported)-787
Total Stockholder Equity (calculated)-787
+/-0
Other
Capital Stock1,925
Cash and Short Term Investments 9,600
Common Stock Shares Outstanding 31,427
Liabilities and Stockholders Equity 14,705
Net Debt -1,515
Net Invested Capital 6,538
Net Tangible Assets -787
Net Working Capital 5,711
Short Long Term Debt Total 8,085



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
> Total Assets 
6,042
4,682
3,808
3,519
3,341
9,350
14,213
14,705
14,70514,2139,3503,3413,5193,8084,6826,042
   > Total Current Assets 
5,853
4,420
3,405
3,272
3,099
8,522
13,441
12,891
12,89113,4418,5223,0993,2723,4054,4205,853
       Cash And Cash Equivalents 
4,091
1,427
797
1,684
1,318
5,586
11,016
9,600
9,60011,0165,5861,3181,6847971,4274,091
       Net Receivables 
0
258
571
304
430
625
337
1,151
1,1513376254303045712580
       Inventory 
1,386
2,144
1,964
1,271
1,235
1,598
1,472
2,139
2,1391,4721,5981,2351,2711,9642,1441,386
       Other Current Assets 
376
849
644
317
546
1,338
954
1,151
1,1519541,338546317644849376
   > Long-term Assets 
190
262
403
248
242
829
772
1,815
1,815772829242248403262190
       Property Plant Equipment 
107
160
299
206
184
765
705
1,268
1,268705765184206299160107
       Intangible Assets 
0
136
268
186
138
159
0
0
001591381862681360
       Long-term Assets Other 
82
102
104
42
58
63
67
546
5466763584210410282
> Total Liabilities 
3,193
4,966
10,475
8,130
22,101
8,424
14,101
15,492
15,49214,1018,42422,1018,13010,4754,9663,193
   > Total Current Liabilities 
2,455
4,120
4,843
5,554
18,727
5,315
5,966
7,180
7,1805,9665,31518,7275,5544,8434,1202,455
       Short-term Debt 
0
0
0
2,820
12,073
659
264
283
28326465912,0732,820000
       Short Long Term Debt 
0
0
0
2,820
12,073
459
0
0
0045912,0732,820000
       Accounts payable 
1,268
1,304
1,803
909
1,908
1,687
2,013
2,193
2,1932,0131,6871,9089091,8031,3041,268
       Other Current Liabilities 
1,187
2,816
3,039
1,825
4,746
2,969
3,689
4,704
4,7043,6892,9694,7461,8253,0392,8161,187
   > Long-term Liabilities 
738
846
5,632
2,576
3,374
3,110
8,135
8,312
8,3128,1353,1103,3742,5765,632846738
       Long term Debt Total 
0
0
4,664
1,757
2,582
2,566
0
0
002,5662,5821,7574,66400
       Other Liabilities 
0
846
968
819
792
544
539
510
5105395447928199688460
> Total Stockholder Equity
2,849
-285
-6,668
-4,611
-18,760
926
113
-787
-787113926-18,760-4,611-6,668-2852,849
   Common Stock
3,806
4,411
860
955
888
1,307
1,635
1,925
1,9251,6351,3078889558604,4113,806
   Retained Earnings -142,695-119,080-99,974-85,003-71,082-62,857-53,501-41,944
   Capital Surplus 
0
48,623
55,438
65,157
64,963
100,661
0
0
00100,66164,96365,15755,43848,6230
   Treasury Stock0000-193000
   Other Stockholders Equity 
40,987
48,852
55,458
65,708
65,577
100,053
118,312
139,983
139,983118,312100,05365,57765,70855,45848,85240,987



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue371
Cost of Revenue-77
Gross Profit294294
 
Operating Income (+$)
Gross Profit294
Operating Expense-22,907
Operating Income-22,614-22,614
 
Operating Expense (+$)
Research Development-
Selling General Administrative5,098
Selling And Marketing Expenses2,079
Operating Expense22,9077,177
 
Net Interest Income (+$)
Interest Income0
Interest Expense-573
Net Interest Income-572-572
 
Pretax Income (+$)
Operating Income-22,614
Net Interest Income-572
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-23,222-22,005
EBIT - interestExpense = -23,222
-23,222
-23,043
Interest Expense573
Earnings Before Interest and Taxes (ebit)-22,649-22,649
Earnings Before Interest and Taxes (ebitda)-22,241
 
After tax Income (+$)
Income Before Tax-23,222
Tax Provision-393
Net Income From Continuing Ops-23,615-23,615
Net Income-23,615
Net Income Applicable To Common Shares-23,615
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses22,984
Total Other Income/Expenses Net-608572
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
IASP.MI
5 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of IASP.MI.

IASP.MI Daily Candlestick Chart
HSTE.MI
8 minutes ago

I found you a Golden Cross on the daily chart of HSTE.MI.

HSTE.MI Daily Candlestick Chart
HMCH.MI
11 minutes ago

I found you a Golden Cross on the daily chart of HMCH.MI.

HMCH.MI Daily Candlestick Chart
MBT.LSE
12 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of MBT.LSE.

MBT.LSE Daily Candlestick Chart
LAND.LSE
21 minutes ago

I found you a Golden Cross on the daily chart of LAND.LSE.

LAND.LSE Daily Candlestick Chart
IUVF.LSE
26 minutes ago

I found you a Death Cross on the daily chart of IUVF.LSE.

IUVF.LSE Daily Candlestick Chart
INRL.LSE
31 minutes ago

I found you a Death Cross on the daily chart of INRL.LSE.

INRL.LSE Daily Candlestick Chart
IDHC.LSE
41 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of IDHC.LSE.

IDHC.LSE Daily Candlestick Chart
IAPD.LSE
41 minutes ago

I found you a Golden Cross on the daily chart of IAPD.LSE.

IAPD.LSE Daily Candlestick Chart
G.MI
43 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of G.MI.

G.MI Daily Candlestick Chart
EVAL.F
47 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of EVAL.F.

EVAL.F Daily Candlestick Chart
GFRD.LSE
49 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of GFRD.LSE.

GFRD.LSE Daily Candlestick Chart
ENGS.MI
52 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ENGS.MI.

ENGS.MI Daily Candlestick Chart
EMDV.MI
53 minutes ago

I found you a Golden Cross on the daily chart of EMDV.MI.

EMDV.MI Daily Candlestick Chart
BYS.SW
59 minutes ago

I found you a Golden Cross on the daily chart of BYS.SW.

BYS.SW Daily Candlestick Chart
ASRUSA.SW
59 minutes ago

I found you a Golden Cross on the daily chart of ASRUSA.SW.

ASRUSA.SW Daily Candlestick Chart
TRAD.ST
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TRAD.ST.

TRAD.ST Daily Candlestick Chart
MLAIU.NASDAQ
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MLAIU.NASDAQ.

MLAIU.NASDAQ Daily Candlestick Chart
BRKHU.NASDAQ
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of BRKHU.NASDAQ.

BRKHU.NASDAQ Daily Candlestick Chart
SPXNTR.INDX
1 hour ago

I found you a Golden Cross on the daily chart of SPXNTR.INDX.

SPXNTR.INDX Daily Candlestick Chart
SP500NTR.INDX
1 hour ago

I found you a Golden Cross on the daily chart of SP500NTR.INDX.

SP500NTR.INDX Daily Candlestick Chart
S5TW.INDX
1 hour ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of S5TW.INDX.

S5TW.INDX Daily Candlestick Chart
NDTW.INDX
1 hour ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of NDTW.INDX.

NDTW.INDX Daily Candlestick Chart
AVLD.INDX
1 hour ago

I found you a MACD Bearish Reversal Divergence on the daily chart of AVLD.INDX.

AVLD.INDX Daily Candlestick Chart
ADVQ.INDX
1 hour ago

I found you a Death Cross on the daily chart of ADVQ.INDX.

ADVQ.INDX Daily Candlestick Chart